LT3197B - Use of quinones in the treatmet of cancer or aids - Google Patents

Use of quinones in the treatmet of cancer or aids Download PDF

Info

Publication number
LT3197B
LT3197B LTIP329A LTIP329A LT3197B LT 3197 B LT3197 B LT 3197B LT IP329 A LTIP329 A LT IP329A LT IP329 A LTIP329 A LT IP329A LT 3197 B LT3197 B LT 3197B
Authority
LT
Lithuania
Prior art keywords
composition according
composition
quinone
hydrogen
mol
Prior art date
Application number
LTIP329A
Other languages
English (en)
Lithuanian (lt)
Inventor
Washington Odur Ayuko
Original Assignee
Radopath Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radopath Ltd filed Critical Radopath Ltd
Publication of LTIP329A publication Critical patent/LTIP329A/xx
Publication of LT3197B publication Critical patent/LT3197B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B1/00—Dyes with anthracene nucleus not condensed with any other ring
    • C09B1/02—Hydroxy-anthraquinones; Ethers or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0033—Blends of pigments; Mixtured crystals; Solid solutions
    • C09B67/0034—Mixtures of two or more pigments or dyes of the same type
    • C09B67/0038—Mixtures of anthraquinones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTIP329A 1991-02-13 1993-02-05 Use of quinones in the treatmet of cancer or aids LT3197B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919103075A GB9103075D0 (en) 1991-02-13 1991-02-13 Trinitrobenzene derivatives and their therapeutic use

Publications (2)

Publication Number Publication Date
LTIP329A LTIP329A (en) 1994-08-25
LT3197B true LT3197B (en) 1995-03-27

Family

ID=10689992

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP329A LT3197B (en) 1991-02-13 1993-02-05 Use of quinones in the treatmet of cancer or aids

Country Status (30)

Country Link
EP (1) EP0499467A3 (fr)
JP (1) JPH06505231A (fr)
CN (1) CN1064407A (fr)
AP (1) AP549A (fr)
AU (2) AU1233992A (fr)
BG (1) BG61025B1 (fr)
BR (1) BR9205642A (fr)
CA (1) CA2104009A1 (fr)
CZ (1) CZ166893A3 (fr)
DZ (1) DZ1559A1 (fr)
FI (1) FI933595A7 (fr)
GB (2) GB9103075D0 (fr)
GT (1) GT199200009A (fr)
HU (1) HUT65634A (fr)
IE (1) IE920464A1 (fr)
IL (1) IL100906A (fr)
IN (1) IN178929B (fr)
IS (1) IS3814A (fr)
JO (1) JO1719B1 (fr)
LT (1) LT3197B (fr)
MA (1) MA22443A1 (fr)
MX (1) MX9200622A (fr)
MY (1) MY131098A (fr)
NO (1) NO932681L (fr)
NZ (2) NZ240487A (fr)
OA (2) OA09535A (fr)
SK (1) SK87993A3 (fr)
TN (1) TNSN92015A1 (fr)
WO (1) WO1992014454A1 (fr)
ZA (1) ZA921037B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103075D0 (en) 1991-02-13 1991-03-27 Washington Odur Ayuko Trinitrobenzene derivatives and their therapeutic use
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
IL113025A0 (en) * 1994-03-17 1995-06-29 Radopath Ltd Anti-viral and anti-cancer agents
ATE188870T1 (de) * 1994-10-04 2000-02-15 Lohmann Rudolf Lomapharm Lösungen von anthrachinonen zur parenteralen applikation
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
AU2008285325A1 (en) 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296136A1 (en) 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
AU2008296176A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
AU2008296072A1 (en) 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
EP2060562A1 (fr) * 2007-11-16 2009-05-20 Laboratoire Medidom S.A. Dérivés de sulfonate de dioxoanthracène
US8512961B2 (en) 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
EP2222323A4 (fr) 2007-11-19 2012-07-25 Bionovo Inc Procédé de fabrication d'extrait purifié de la scutellaria barbata d.don
CA2727018A1 (fr) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones et analogues provenant de rheum palmatum pour le traitement d'etats a mediation par le recepteur beta de l'estrogene
WO2013055913A2 (fr) 2011-10-14 2013-04-18 Emory University Inhibiteurs de pgam1 et procédés associés
CZ304335B6 (cs) * 2012-02-22 2014-03-12 Mikrobiologický ústav AV ČR, v. v. i. Submerzní kmeny Quambalaria sp. CCM 8372 a CCM 8373, směs naftochinonových barviv jimi produkovaná, způsob jejich produkce a použití
CA3105413A1 (fr) * 2018-07-17 2020-01-23 Pili Derives anthraquinoniques et leur utilisation en tant qu'agents colorants

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015200A2 (fr) 1990-04-03 1991-10-17 Radopath Limited Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
GB2254554A (en) 1991-02-13 1992-10-14 Radopath Ltd Pharmaceutical quinone composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
JPS6054286B2 (ja) * 1979-09-18 1985-11-29 江澤 林 免疫増強剤
JPS6043210A (ja) * 1983-08-18 1985-03-07 Tdk Corp 磁気ヘツド及びその製造方法
DE3431236A1 (de) * 1984-08-24 1986-02-27 Carnivora-Deutschland GmbH, 7109 Jagsthausen Verwendung von 1,4-naphthochinon-derivaten in niedrigen konzentrationen zur immunstimulation
DE3601065A1 (de) * 1986-01-16 1987-07-23 Behringwerke Ag Chinon-derivate als antitumormittel
EP0348509B1 (fr) * 1987-12-10 1993-03-24 TSUMURA &amp; CO. Medicament antiretroviral
JP2804302B2 (ja) * 1988-08-16 1998-09-24 ザ ウエルカム フアウンデーション リミテッド 治療剤
DE4013023A1 (de) * 1990-04-24 1991-11-07 Lohmann Rudolf Lomapharm Verwendung von anthrachinonderivaten zur prophylaxe und therapie von viruserkrankungen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991015200A2 (fr) 1990-04-03 1991-10-17 Radopath Limited Utilisation trinitrobenzenes ou d'acide carminique pour le traitement du cancer ou de maladies virales
GB2254554A (en) 1991-02-13 1992-10-14 Radopath Ltd Pharmaceutical quinone composition

Also Published As

Publication number Publication date
ZA921037B (en) 1992-11-25
IL100906A0 (en) 1992-11-15
CA2104009A1 (fr) 1992-08-14
BR9205642A (pt) 1994-06-21
TNSN92015A1 (fr) 1993-06-08
DZ1559A1 (fr) 2002-02-17
EP0499467A2 (fr) 1992-08-19
FI933595A0 (fi) 1993-08-13
GB9203084D0 (en) 1992-03-25
OA09535A (en) 1992-11-15
OA09810A (en) 1994-04-15
BG98041A (bg) 1994-05-27
FI933595A7 (fi) 1993-08-13
CN1064407A (zh) 1992-09-16
AP9200356A0 (en) 1992-04-30
GB2254554B (en) 1995-09-20
NZ240487A (en) 1994-03-25
AU5590696A (en) 1996-08-08
GB9103075D0 (en) 1991-03-27
IE920464A1 (en) 1992-08-12
IS3814A (is) 1992-08-14
MX9200622A (es) 1992-11-01
HU9302347D0 (en) 1993-10-28
IL100906A (en) 1996-09-12
EP0499467A3 (en) 1992-12-16
BG61025B1 (bg) 1996-09-30
MY131098A (en) 2007-07-31
CZ166893A3 (en) 1994-03-16
NO932681D0 (no) 1993-07-26
WO1992014454A1 (fr) 1992-09-03
MA22443A1 (fr) 1992-10-01
NO932681L (no) 1993-10-07
GB2254554A (en) 1992-10-14
AP549A (en) 1996-11-01
JO1719B1 (en) 1992-12-15
AU1233992A (en) 1992-09-15
HUT65634A (en) 1994-07-28
NZ241593A (en) 1995-05-26
JPH06505231A (ja) 1994-06-16
SK87993A3 (en) 1993-12-08
IN178929B (fr) 1997-07-19
GT199200009A (es) 1993-08-06
LTIP329A (en) 1994-08-25

Similar Documents

Publication Publication Date Title
EP0201275B1 (fr) Compositions pharmaceutiques pour le traitement des métastases de tumeurs cancéreuses
AP549A (en) Pharmaceutical composition comprising at least one quinone for use in the treatment of cancer and virus infections.
KR102034606B1 (ko) 데옥시콜린산 및 그의 염들의 제형물들
EA009939B1 (ru) Жирные кислоты со средней длиной цепи, глицериды и аналоги в качестве стимуляторов эритропоэза
BG63612B1 (bg) Състав и метод за профилактика и лечение на нiv идруги инфекциозни заболявания при човека
US6063814A (en) Phorbol esters as anti-neoplastic and white blood cell elevating agents
EP0281380A2 (fr) Interaction synergique d&#39;interleukine-2 d&#39;ARN à double chaîne
AU7971994A (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
Yamanaka et al. Elevation of serum lipid peroxide level associated with doxorubicin toxicity and its amelioration by [dl]-α-tocopheryl acetate or coenzyme Q10 in mouse (doxorubicin, toxicity, lipid peroxide, tocopherol, coenzyme Q10)
US20040101573A1 (en) Injectable composition for cancer treatment
AU662883B2 (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
OA12862A (en) Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone.
De Somer et al. Influence of basic antibiotics on serum-and liver-cholesterol concentrations in chicks
EP2664621A1 (fr) Produit antiviral
JP2004315470A (ja) ヨウ化ナトリウム含有製剤
US5955498A (en) Agent for prophylaxis and therapy of diseases
US20100016244A1 (en) D-glucopyranose 1-[3,5-bis (1,1-dimethylethy)-4-hydroxybenzoate] and its derivatives, preparation and use thereof
HRP920891A2 (en) Quinone preparation
JPH10251151A (ja) 癌転移阻害剤
Alkhawajah et al. Treatment of cutaneous leishmaniosis with antimony: intramuscular versus intralesional administration
Le Fichoux et al. Hexadecylphosphocholine and murine visceral leishmaniosis
Woldav et al. Response to antileishmanial chemotherapy in leishmania-HIV co-infected patients is influenced by the HIV viral load levels before initiation of therapy
WO1996011679A1 (fr) Compositions comprenant de l&#39;acide dichloroacetique tamponne au carbonate/bicarbonate et procedes de traitement de troubles metaboliques et cardiovasculaires
LT3173B (en) Use of trinitrobenzenes or carminic acid in the treatment of cancer or viral diseases
CZ27946U1 (cs) Farmaceutický prostředek s virucidním a antibakteriálním účinkem

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19980205